Analysts exoect revenue to rise by more than 180%, to $762 million, this year, and then grow another 45%, to $1.1 billion, next year, pushing the biotech company out of the red and into the black ...

The startup, Veraxa, has $253 million in cash and is raising a crossover funding round to support a pipeline of T cell ...

greater control over the biotech company’s operations. Pete Salzmann, Immunovant’s current CEO and board member, is retiring. He will be replaced by Eric Venker, Roivant’s current president ...

One relatively small biotech company has made a breakthrough that could be used to treat a range of cancer. While it's been a poor performer for the past few years despite promising growth ...

Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund” ...

This purchase signals a growing interest in the established biotech company, known for its innovative treatments and steady market presence. Continuing its investment in the sector, ARK also ...

Turbine's virtual lab enables in silico experimentation using a vast library of cell models, patient-derived samples and virtual patients. By computationally predicting therapy effects, drug ...

For instance, a biotech firm working on breast cancer treatments, which has nearly 300,000 new cases in the U.S. each year, might be more valuable than a company that is developing drugs for ...

For instance, the Tel Aviv-based CytoReason, a biotechnology company which develops software to model and map various treatments across different patient groups and diseases has/ received backing ...

The multinational pharmaceutical and biotechnology company invested $44 million to expand its existing operation in Myerstown to increase production and packaging capabilities for its over-the ...

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. (“Sana” or the “Company”) (NASDAQ ...

GeoVax to Host Conference Call at 4:30 PM ET ATLANTA, GA - April 23, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and ...